Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction (scientific article published on 14 May 2012)

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

Q30884235

Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

Q30912415

Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD

Q33336612

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data

Q33386435

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

Q33950766

The novel adipocytokine visfatin exerts direct cardioprotective effects

Q34001681

Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation.

Q34235614

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

Q34377294

Silent information regulator 1 protects the heart from ischemia/reperfusion

Q34412288

The inflammatory response in myocardial infarction

Q34463456

Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.

Q34845287

Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.

Q34875121

Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity

Q37077995

Oxidative stress and left ventricular remodelling after myocardial infarction

Q37338724

Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner

Q39795774

Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress

Q39938306

Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor

Q40413865

FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis

Q40617327

Cardiac troponin-I: a biochemical marker for cardiac cell necrosis

Q40700665

Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.

Q41829105

Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool

Q42009559

CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

Q46151813

Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction

Q46628006

TNF regulates cellular NAD+ metabolism in primary macrophages

Q46975232

Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production

Q46975502

Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway

Q48465761

Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.

Q53378752

The specific role of chemokines in atherosclerosis.

Q53555491

Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice

Q58197658

The plasticity of dendritic cell responses to pathogens and their components

Q77069892

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

Q81370250

Circulating visfatin in chronic obstructive pulmonary disease

Q82836787

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

Q83261721

P433

issue

P921

main subject

myocardial infarction

Q12152

niacinamide

Q192423

P304

page(s)

630-641

P577

publication date

2012-05-14

P1433

published in

Antioxidants & Redox Signaling

Q4775078

P1476

title

Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction

P478

volume

Reverse relations

cites work (P2860)

Q38775998	11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI.
Q35415815	Adipokines as drug targets in diabetes and underlying disturbances.
Q36771997	Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model
Q37151029	CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells
Q54980716	Dunye Guanxinning Improves Acute Myocardial Ischemia-Reperfusion Injury by Inhibiting Neutrophil Infiltration and Caspase-1 Activity.
Q33708531	FK866 attenuates acute hepatic failure through c-jun-N-terminal kinase (JNK)-dependent autophagy
Q27022606	From sirtuin biology to human diseases: an update
Q54314174	Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways.
Q28544407	Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury
Q60306046	Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction
Q36907206	Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice
Q43193506	Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD(+) protects the heart against pressure overload
Q99237973	NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death
Q38885136	NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy.
Q37175524	Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling
Q89345508	Neutrophils: Friend, foe, or contextual ally in myocardial healing
Q33721511	Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion
Q34103687	Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury
Q36162234	Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Q38626782	Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
Q36387714	Protective effects of sirtuins in cardiovascular diseases: from bench to bedside
Q39195646	Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin
Q90255200	SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells
Q42455903	SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts.
Q36211215	Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes
Q90187486	Silencing of ATP2B1-AS1 contributes to protection against myocardial infarction in mouse via blocking NFKBIA-mediated NF-κB signalling pathway
Q38579945	Sirt6 regulates dendritic cell differentiation, maturation, and function
Q33602183	Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats
Q54977650	The Emergence of the Nicotinamide Riboside Kinases in the regulation of NAD+ Metabolism.
Q36436005	The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses
Q39134471	The Role of Inflammation in Cardiovascular Outcome.
Q34623236	The function of nicotinamide phosphoribosyltransferase in the heart.
Q46851060	Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis
Q36745089	Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice
Q46567372	Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury
Q36970010	Visfatin/Nampt: an adipokine with cardiovascular impact

P356	DOI	10.1089/ARS.2011.4487
P8608	Fatcat ID	release_iyjc5po2cjcelfzyhdiwq3wv6u
P932	PMC publication ID	3549207
P698	PubMed publication ID	22452634
P5875	ResearchGate publication ID	221977641